ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 215 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $475,000 | -40.2% | 11,738 | -14.8% | 0.01% | -33.3% |
| Q2 2015 | $794,000 | -15.9% | 13,778 | -7.0% | 0.02% | -16.7% |
| Q1 2015 | $944,000 | +39.2% | 14,813 | +34.0% | 0.02% | +20.0% |
| Q4 2014 | $678,000 | +99.4% | 11,052 | +26.3% | 0.02% | +66.7% |
| Q3 2014 | $340,000 | +51.8% | 8,751 | +34.1% | 0.01% | +50.0% |
| Q2 2014 | $224,000 | +8.7% | 6,527 | +38.3% | 0.01% | 0.0% |
| Q1 2014 | $206,000 | -19.5% | 4,721 | -26.6% | 0.01% | -25.0% |
| Q4 2013 | $256,000 | +19.1% | 6,433 | +12.3% | 0.01% | +14.3% |
| Q3 2013 | $215,000 | +38.7% | 5,727 | -0.3% | 0.01% | +16.7% |
| Q2 2013 | $155,000 | – | 5,746 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |